Skip to main content
TipRanks
Go Ultimate75% OFF

SATUDORA HOLDINGS CO., LTD. (3544) AI Stock Analysis

1 Followers
JP:3544

SATUDORA HOLDINGS CO., LTD.

(TSE/TYO:3544)

Select Model
Rating:54Neutral
Price Target:JPY 1,271.00â–²(1.76% Upside)
Action:reiterated
Date:09/25/26

The overall score of 54 is heavily weighed down by a highly unappealing valuation and weak bottom-line profitability. While the company's long-term technical uptrend and ongoing debt reduction efforts offer some foundational support, the extremely high P/E ratio and declining free cash flow present substantial risks that limit its current investment appeal.

Positive Factors
Steady Revenue GrowthBroadly stable to growing revenue indicates continued demand for the group’s drugstore, health, beauty, and daily-necessity offerings. This provides a durable operating base and supports ongoing store activity, even though the latest growth rate has moderated materially.
Negative Factors
Thin, Declining ProfitabilityVery low net margins leave limited protection against weaker demand or higher costs, while the sharp decline in net income shows earnings are vulnerable despite stable revenue. This restricts internal reinvestment capacity and makes sustained improvement in operating efficiency important.

SATUDORA HOLDINGS CO., LTD. (3544) vs. iShares MSCI Japan ETF (EWJ)

-10%0%10%20%30%40%50%60%70%JP:3544+58.23%EWJ+16.06%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 17.21B
Dividend Yield
0.96%
Average Volume (3M)
14.36K
Price to Earnings (P/E)
104.4
Beta (1Y)
0.02
Revenue Growth
-0.23%
EPS Growth
-77.29%
Country
Japan
Employees
1,099
Sector
General
Sector Strength
55
Industry
Medical - Pharmaceuticals

SATUDORA HOLDINGS CO., LTD. Business Overview & Revenue Model

Company Description

Satudora Holdings Co., Ltd. is a Japanese enterprise primarily focused on operating drugstores and dispensing pharmacies. Its business operations are structured into two main divisions: Retail Business and IT Solution Business. Beyond its core retail...

How the Company Makes Money

SATUDORA HOLDINGS primarily makes money through retail sales generated by its drugstore operations. The main revenue stream is product sales to consumers in its stores, typically spanning (where disclosed) pharmaceuticals/OTC medicines, health and be...

SATUDORA HOLDINGS CO., LTD. Financial Statement Overview

Summary

Financial performance reflects stable top-line revenue and an improving balance sheet with steadily decreasing debt. However, this is heavily offset by extremely thin profit margins, a low return on equity, and a concerning multi-year decline in free cash flow generation.

Income Statement

55Neutral

Balance Sheet

62Positive

Cash Flow

50Neutral
Financial statement breakdown
BreakdownTTMMay 2025May 2024May 2023May 2022May 2021
Income Statement
Total Revenue100.33B100.57B100.17B95.52B87.48B83.24B
Gross Profit25.97B26.11B24.29B22.31B20.03B19.38B
EBITDA2.74B3.00B2.80B2.36B1.58B1.81B
Net Income164.00M434.00M768.00M470.00M87.00M575.00M
Balance Sheet
Total Assets50.72B45.15B46.45B45.14B43.28B38.48B
Cash, Cash Equivalents and Short-Term Investments4.87B1.48B2.67B2.67B2.31B2.66B
Total Debt13.29B15.23B17.21B17.39B18.11B12.00B
Total Liabilities40.68B34.93B36.52B35.90B34.44B29.80B
Stockholders Equity9.94B10.11B9.80B9.13B8.73B8.63B
Cash Flow
Free Cash Flow0474.00M1.32B2.10B-3.81B1.26B
Operating Cash Flow02.32B2.60B3.54B-1.77B3.37B
Investing Cash Flow0-1.14B-1.67B-1.92B-2.87B1.20B
Financing Cash Flow0-2.37B-935.00M-1.26B4.00B-3.39B

SATUDORA HOLDINGS CO., LTD. Technical Analysis

Technical Analysis SentimentPositive
Last Price1249.00

Price Trends

50DMA1247.86Positive
100DMA1231.28Positive
200DMA1037.66Positive

Market Momentum

MACD1.02Negative
RSI55.53Neutral
STOCH64.65Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3544, the sentiment is Positive. The current price of 1249.00 is above the 20-day moving average (MA) of 1247.95, above the 50-day MA of 1247.86, and above the 200-day MA of 1037.66, indicating a bullish trend. The MACD of 1.02 indicates Negative momentum. The RSI at 55.53 is Neutral, neither overbought nor oversold. The STOCH value of 64.65 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3544.

SATUDORA HOLDINGS CO., LTD. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:3544 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:3391JP:339181OutperformJPY 1.11T19.567.13%1.88%――
JP:7649JP:764969NeutralJPY 522.71B16.939.94%1.28%8.97%-29.54%
JP:9989JP:998969NeutralJPY 449.92B14.4811.15%3.39%4.32%0.18%
JP:3349JP:334960NeutralJPY 496.38B15.67―1.29%8.99%3.61%
JP:3549JP:354959NeutralJPY 486.11B25.31―0.29%12.54%15.87%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
JP:3544JP:354454NeutralJPY 17.34B104.43―0.96%-0.23%-77.29%

* General Sector Average

Performance Comparison

-20%0%20%40%60%JP:3544JP:9989JP:7649JP:3391JP:3349JP:3549Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:3544 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:3544SATUDORA HOLDINGS CO., LTD.1249.00448.7956.08%
JP:9989Sundrug Co 3924.00-187.45-4.56%
JP:7649Sugi Holdings Co 1416.50-292.70-17.12%
JP:3391TSURUHA Holdings 2500.00-202.22-7.48%
JP:3349COSMOS Pharmaceutical Corporation6437.00-929.03-12.61%
JP:3549KUSURI NO AOKI HOLDINGS CO.,LTD.5073.001236.3532.22%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 25, 2026